Jun 23, 2024, 14:07
Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma
Mark Roschewski, Senior Clinician in the Lymphoid Malignancies Branch at the National Cancer Institute, shared a post on X:
“Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma | New England Journal of Medicine
Concept by Wyndham Wilson, pre-clinical rationale by Lou Staudt, and study led by Christopher Melani.
Thanks to all patients.”
Read further.
Source: Mark Roschewski/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 7, 2024, 11:53
Nov 7, 2024, 11:37
Nov 7, 2024, 08:16
Nov 7, 2024, 07:44
Nov 7, 2024, 07:38
Nov 7, 2024, 07:27